Kinnate Biopharma Inc. Current Ratio 2021-2023 | KNTE
Kinnate Biopharma Inc. current ratio from 2021 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2023-12-31 |
$0.16B |
$0.01B |
13.19 |
2023-09-30 |
$0.17B |
$0.02B |
10.80 |
2023-06-30 |
$0.19B |
$0.02B |
11.96 |
2023-03-31 |
$0.21B |
$0.02B |
11.31 |
2022-12-31 |
$0.23B |
$0.02B |
13.45 |
2022-09-30 |
$0.26B |
$0.02B |
17.02 |
2022-06-30 |
$0.27B |
$0.01B |
23.30 |
2022-03-31 |
$0.28B |
$0.01B |
20.15 |
2021-12-31 |
$0.26B |
$0.01B |
20.88 |
2021-09-30 |
$0.26B |
$0.01B |
25.31 |
2021-06-30 |
$0.26B |
$0.01B |
31.09 |
2021-03-31 |
$0.25B |
$0.01B |
32.23 |
2020-12-31 |
$0.40B |
$0.01B |
54.79 |
2020-09-30 |
$0.00B |
|
0.00 |
2020-06-30 |
$0.00B |
|
0.00 |
2020-03-31 |
$0.00B |
|
0.00 |